Acute Heart Failure
Links shared publicly online about this topic
Symposier - Nesiritide for Acute Heart Failure
symposier.com — “Uploaded and shared in Youtube by: ElsGlobalMedicalNews --" Results from the 7,000-patient ASCEND-HF trial show that nesiritide was safe for treating patients with acute decompensated heart failure, but on average it only exerted a small dyspnea. Despite that, nesiritide has a role as a second-line agent because of its safety and ability to help certain patients. Read the story: http://bit.ly/evpUhy” View full resource at symposier.com
Most Recently Shared on December 3, 2010 at 11:48 pm By:
Symposier Cardiology Cardiology and Health Business
Nesiritide for Acute Heart Failure, Results from ASCENT-HF show nesiritide is safe. http://bit.ly/hZkpDY
Pheochromocytoma Presenting as Acute Heart Failure Leading to Cardiogenic Shock and Multiorgan Failure
hindawi.com — “Pheochromocytoma is an endocrine tumor classically presenting with headache, paroxysmal hypertension, and palpitations. We discuss the case of a young male, presenting with acute heart failure and cardiogenic shock requiring stabilization with an intra-aortic balloon pump and a combination of ionotropes and vasopressors. Pheochromocytoma was diagnosed by CT scan, as well as urine and plasma metanephrines. After pretreatment with phenoxy-benzamine, the patient underwent adrenalectomy with subsequ” View full resource at hindawi.com
Most Recently Shared on May 12, 2011 at 1:35 am By:
Pheochromocytoma Presenting as Acute Heart Failure Leading to Cardiogenic Shock and Multiorgan Failure: Pheochro... http://bit.ly/iZhyYO
Continued beta blockade safe in randomized acute heart-failure trial
theheart.org — “Short-term outcomes are the same whether beta blockers are continued or withheld at hospitalization for acute decompensated heart failure, and there are good reasons to continue them, according to researchers.” View full resource at theheart.org
Most Recently Shared on September 14, 2009 at 3:21 pm By:
heartwire: B-CONVINCED: Maintain beta blockers during acute heart failure management http://bit.ly/WBIUT
Early BNP-level changes may be prognostic in acute heart failure
theheart.org — “A drop in BNP over the first few hospitalization days independently predicted survival gains over six months in a post hoc analysis from a randomized trial. Researchers say it's time for a prospective trial in acute decompensated heart failure testing the value of treatment aimed specifically at pushing down natriuretic-peptide levels.” View full resource at theheart.org
Most Recently Shared on June 18, 2009 at 8:09 pm By:
heartwire: Early natriuretic-peptide level changes seen to predict late acute-HF outcomes http://bit.ly/l9DVr
Trevena Initiates Phase 2 Study Of TRV120027 For Acute Heart Failure
medicalnewstoday.com — “Trevena Inc., the leader in G-protein coupled receptor (GPCR) biased ligand drug discovery, announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin” View full resource at medicalnewstoday.com
Most Recently Shared on February 25, 2011 at 2:07 pm By:
Trevena Initiates Phase 2 Study Of TRV120027 For Acute Heart Failure: Trevena Inc., the leader in G-protein coupled rec.. http://dld.bz/P6Ge
Acoustic cardiography improves diagnostic accuracy in acute heart failure
news-medical.net — “It allows them to hear the S3, an abnormal third sound in the heart's rhythm strongly associated with cardiac disease and heart failure. However, the low-frequency, low-pitch sound is notoriously very difficult to hear with a stethoscope alone.It allows them to hear the S3, an abnormal third sound in the heart's rhythm strongly associated with cardiac disease and heart failure. However, the low-frequency, low-pitch sound is notoriously very difficult to hear with a stethoscope alone.” View full resource at news-medical.net
Most Recently Shared on August 11, 2010 at 10:43 am By:
Acoustic cardiography improves diagnostic accuracy in acute heart failure: It allows them to hear the S3, an abnor... http://bit.ly/dvexMQ
Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine "
eurjhf.oxfordjournals.org — “Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine " Eur J Heart Fail” View full resource at eurjhf.oxfordjournals.org
Most Recently Shared on April 12, 2010 at 9:02 am By:
European Cardiology Cardiology and Medical Society
Scientific statement on assessing and grading congestion in acute #HeartFailure http://tinyurl.com/y3zf2y7
Medical News: Drug Flops for Acute Heart Failure - in Cardiovascular, CHF from MedPage Today
medpagetoday.com — “Among patients with acute heart failure, nesiritide (Natrecor) had no significant effect on dyspnea or the rate of heart failure hospitalization or death at 30 days, a large, randomized trial showed.” View full resource at medpagetoday.com
Most Recently Shared on July 7, 2011 at 2:39 pm By:
Drug Flops for Acute Heart Failure (CME/CE) http://bit.ly/pssBx6
Acute Heart Failure More Accurately Diagnosed In Emergency Rooms By New Mathematical Model
medicalnewstoday.com — “Researchers at st. michael's hospital have developed the first mathematical model in cardiology and emergency medicine to more quickly and reliably diagnose acute heart failure (ahf) in emergency ” View full resource at medicalnewstoday.com
Most Recently Shared on October 16, 2009 at 3:47 pm By:
MNT Cardiovascular Health News
Acute Heart Failure More Accurately Diagnosed In Emergency Rooms By New Mathematical Model: Researchers at St. M.. http://bit.ly/1dw0yo
New Mathematical Model More Accurately Diagnoses Acute Heart Failure In Emergency Rooms
sciencedaily.com — “Researchers have developed the first mathematical model in cardiology and emergency medicine to more quickly and reliably diagnose acute heart failure in emergency room patients. Research findings have been shown to help physicians diagnose AHF with greater accuracy.” View full resource at sciencedaily.com
Most Recently Shared on October 18, 2009 at 5:30 pm By:
New Mathematical Model More Accurately Diagnoses Acute Heart Failure In Emergency Rooms http://tinyurl.com/ygbhkov
Industry-Funded Study: Nesiritide 'Cannot Be Recommended for Routine Use' in Acute Heart Failure - Physician's First Watch
firstwatch.jwatch.org — “Nesiritide "cannot be recommended for routine use in the broad population of patients with acute heart failure," according to a manufacturer-funded study published in the New England Journal of Medicine. (These results were first . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on July 11, 2011 at 6:35 pm By:
Ves Dimov, M.D. Physician, Doctor, Internist, and Allergist
Nesiritide 'Cannot Be Recommended for Routine Use' in Acute Heart Failure http://t.co/crQkCy4
Phase 2 study of CD-NP for treatment of acute heart failure - MPR
empr.com — “Nile Therapeutics announced dosing of its first patient in a Phase 2 clinical study of its lead product, CD-NP, for the treatment of acute heart failure.” View full resource at empr.com
Most Recently Shared on August 4, 2009 at 6:11 pm By:
MPR News: Phase 2 study of CD-NP for treatment of acute heart failure: Nile Therapeutics announced dosi.. http://bit.ly/17vLAC
Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure
news-medical.net — “Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.” View full resource at news-medical.net
Most Recently Shared on February 24, 2011 at 4:32 am By:
Medicare News: Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure: Trevena Inc., th... http://bit.ly/ihKBxt
FDA grants Fast Track designation to Corthera's relaxin for treating acute heart failure
news-medical.net — “Corthera Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to relaxin, the company's investigational drug for the treatment of acute heart failure (AHF). The Fast Track program facilitates the development and expedites the review of new drugs intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs.” View full resource at news-medical.net
Most Recently Shared on October 3, 2009 at 6:54 am By:
Medicare News: FDA grants Fast Track designation to Corthera's relaxin for treating acute heart f.. http://digg.com/u1DZfM
Beneficial Association of ?-Blocker Therapy On Recovery From Severe Acute Heart Failure Treatment - QualityPoint Technologies
qualitypointtech.net — “Patients hospitalized with HF decompensation may be taken off their beta-blocker. Is this the best long-term management strategy? Critical Care Medicine” View full resource at qualitypointtech.net
Most Recently Shared on May 20, 2011 at 12:45 pm By:
Beneficial Association of Β-Blocker Therapy On Recovery From Severe Acute Heart Failure Treatment: Patients hospi... http://bit.ly/jGAIuf
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Symposier Cardiology
Symposier.com, the technological platform that will allow you (and your colleagues) to share medical information, and much more with medicine professionals.
-
Migraine OW
Organizing migraine resources shared by health experts, advocates, and organizations into WisdomCards.
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
Advertisement
